Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
SU5416 selectively inhibits VEGF-driven mitogenesis in a dose-dependent manner with IC50 of 0
AT-2266 hydrate
5-Difluorophenyl)acetyl]-L-alanyl-2-phenylglycine-1
is an Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect
Pomalidomide4alkylC3acid
ATN-161 Catalog No.:M8510-2 SU5416 selectively inhibits VEGF-driven mitogenesisATN 161 is a small peptide antagonist of integrin alpha5beta1 with potential antineoplastic activity. ATN 161 selectively binds to and blocks the receptor for integrin alpha5beta1, thereby preventing integrin alpha5beta1 binding. This receptor blockade may result in inhibition of endothelial cell cell interactions, endothelial cell matrix interactions, angiogenesis, and tumor progression. Integrin alpha5beta1 is expressed on endothelial cells and
US$ 133.00
US$ 140.00
US$ 245.50
US$ 133.00
US$ 323.00
US$ 290.00